Organization · Accelerator

BioInnovate Ireland

BioInnovate Ireland is a health technology innovation hub at the University of Galway, established in 2011. It focuses on educating healthcare entrepreneurs through needs-led innovation to enhance patient care globally.

AcceleratorProgram host

Overview

What BioInnovate Ireland does

What BioInnovate Ireland is

BioInnovate Ireland is a health technology innovation hub at the University of Galway, established in 2011. It focuses on educating healthcare entrepreneurs through needs-led innovation to enhance patient care globally.

How it participates in the startup ecosystem

The current public profile supports program host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.

Operational profile

Organization status and context

Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.

Operational status
Active
Organization type
Accelerator
Founded
Founded in 2011
Approximate age
About 15 years
Structured capabilities
Program host
Last reviewed
May 7, 2026
What Accelerator means

An accelerator is a structured, short-term program designed to speed up a startup's progress toward product-market fit, traction, fundraising, or scale.

Open the glossary entry

Official channels

Find BioInnovate Ireland elsewhere

Open the official website or a supported primary organization account.

Capability profile

BioInnovate Ireland as a program host

Program thesis

BioInnovate Ireland is a health technology innovation program aimed at improving patient care through needs-led innovation by bringing together clinicians, engineers, scientists, and business professionals.

Focus narrative

BioInnovate focuses on health technology innovation, specifically in medical devices and digital health. The program supports innovation through three key pillars: the BioInnovate Programme, industry and executive training, and the Ian Quinn Centre for Health Technology Innovation. It targets professionals with diverse backgrounds, including clinical, technical, and commercial fields, particularly those with experience in software, AI, or data analytics.

Value and support

Participants receive a tax-free scholarship of €38,000, and academic fees of up to €5,750 are covered. The program is designed to immerse participants in the clinical innovation journey, from identifying unmet needs to developing solutions and strategies for commercialization.

Terms and economics

Indicative investment
$0
Stipend
$38,000

Format and cadence

Typical duration
40 weeks
Format
In Person

Availability

Application state
Not published
Next deadline
February 28, 2026

Focus and fit

Stages
Accelerator
Sectors
Healthcare · Digital Health · Medical Devices
Regions
Europe · Global

Alumni and track record

Alumni context

Notable alumni companies include: Perfuze: Specializes in neurovascular devices for treating acute ischemic stroke. Relevium Medical: Focuses on novel pharmacological hydrogel treatments for chronic pain. LUMA Vision: Develops cardiac navigation technology. FeelTect: Innovates in wound care with smart compression monitoring systems.

Common questions

What to know about BioInnovate Ireland

Upseed classifies BioInnovate Ireland under the Accelerator organization type. Its current public profile includes program host capabilities.

Next step

Keep comparing startup organizations

Return to the organization index or continue through a verified sector, place, peer, or program connected to this profile.

Source and update disclosure

Know what this page is based on

Source basis

Public organization and program material, official websites, and structured Upseed records.

Last reviewed

May 7, 2026

Known limits

Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.

Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.